Crohn’s Disease and Ulcerative Colitis: From Pathophysiology to Novel Therapeutic Approaches-Reference-Cited by-同舟云学术

Crohn’s Disease and Ulcerative Colitis: From Pathophysiology to Novel Therapeutic Approaches

Published:2024-03-19 Issue:3 Volume:12 Page:689
ISSN:2227-9059
Container-title:Biomedicines
language:en
Short-container-title:Biomedicines

Author:

Long Dingpei¹²^ORCID

Affiliation:

1. State Key Laboratory of Resource Insects, Institute of Sericulture and Systems Biology, Southwest University, Chongqing 400715, China

2. Institute for Biomedical Sciences, Center for Inflammation, Immunity & Infection, Digestive Disease Research Group, Georgia State University, Atlanta, GA 30303, USA

Abstract

Inflammatory bowel disease (IBD) is a non-specific autoimmune condition impacting the gastrointestinal tract, encompassing Crohn’s disease (CD) and ulcerative colitis (UC) [...]

Funder

Chongqing Talents: Exceptional Young Talents Project

Academician Foundation Program of Chongqing

Publisher

MDPI AG

Link

https://www.mdpi.com/2227-9059/12/3/689/pdf

Reference35 articles.

1. Inflammatory Bowel Disease;Kaser;Annu. Rev. Immunol.,2010

2. Multidonor intensive faecal microbiota transplantation for active ulcerative colitis: A randomised placebo-controlled trial;Paramsothy;Lancet,2017

3. The intestinal microbiome, barrier function, and immune system in inflammatory bowel disease: A tripartite pathophysiological circuit with implications for new therapeutic directions;Vindigni;Ther. Adv. Gastroenterol.,2016

4. Intestinal Stem Cells and Immune Cell Relationships: Potential Therapeutic Targets for Inflammatory Bowel Diseases;Hou;Front. Immunol.,2021

5. Lactoferrin-mediated macrophage targeting delivery and patchouli alcohol-based therapeutic strategy for inflammatory bowel diseases;Zhao;Acta Pharm. Sin. B,2020